SCHEMBL4600838

SCHEMBL4600838

NC(=O)OS(=O)(=O)NCCc1cccs1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.48
RAB9A P51151 5/20 0.48
SMN1; SMN2 Q16637 4/20 0.48
CA1 P00915 3/20 0.47
CA2 P00918 3/20 0.47
CA12 O43570 2/20 0.47
CA9 Q16790 2/20 0.47
POLB P06746 3/20 0.45
TAAR1 Q96RJ0 3/20 0.44
ALDH1A1 P00352 2/20 0.43
TSHR P16473 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
ADRA2A P08913 2/20 0.42
ADRA2B P18089 2/20 0.42
ADRA2C P18825 2/20 0.42
CA5A P35218 2/20 0.41
CA7 P43166 2/20 0.41
CA5B Q9Y2D0 2/20 0.41
BRD4 O60885 1/20 0.41
LMNA P02545 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7263003 0.77 NPC1 (0.53) NPC1RAB9ASMN1; SMN2CA1CA2
SCHEMBL3208037 0.77 TAAR1 (0.50) NPC1RAB9ASMN1; SMN2CA1CA2
SCHEMBL3217657 0.74 NPC1 (0.50) NPC1RAB9ASMN1; SMN2CA1CA2
SCHEMBL4031932 0.73 POLB (0.69) NPC1RAB9ASMN1; SMN2CA1CA2
SCHEMBL1046498 0.72 POLB (0.50) POLBALDH1A1LMNA
SCHEMBL29145671 0.71 NPC1 (0.62) NPC1RAB9ASMN1; SMN2CA1CA2
Acetic Acid SCHEMBL27263112 0.70 LMNA (0.53) SMN1; SMN2POLBALDH1A1TSHRLMNA
SCHEMBL7658914 0.70 POLB (0.57) NPC1RAB9ASMN1; SMN2POLBTAAR1
SCHEMBL12601569 0.70 SMN1; SMN2 (0.45) NPC1RAB9ASMN1; SMN2CA1CA2
SCHEMBL6564813 0.70 TDP1 (0.56) SMN1; SMN2CA1CA2POLBTAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1912645-A2 THERAPEUTIC AGENT FOR DIABETES Takeda Pharmaceutical Company Limited (JP) 2008-04-23 EP disclosed
WO-2007018314-A2 THERAPEUTIC AGENT FOR DIABETES TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-02-15 WO disclosed